Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Flat index levels can mask underlying shifts among components; still, broader market movements may occur through price changes in parts.
28,641 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Fresh data show XRP whales dispersing their flow beyond Binance, with large transfers gaining share across centralize...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...
As tariffs re-emerge under Section 301, policymakers push a framework that has endured decades of legal challenges. T...
New data from the New York Fed show a sharp rise in household pessimism as rent and food costs rise, threatening cons...
Major appliance brands warn buyers to pace big-ticket purchases as demand cools and prices rise. The article surveys ...
Nebius just announced a strategic partnership aimed at easing power bottlenecks in its AI infrastructure rollout. Thi...
A $900,000 retirement on Florida’s Gulf Coast could work with disciplined housing costs, insurance planning, and care...
Tesla’s shares fall in 2026 as Reddit users grow increasingly bearish, prompting a broader rethink of the EV leader’s...
Li Auto unveiled a $1 billion share repurchase after weaker Q4 deliveries, sending LI higher and triggering a debate ...
Archer Aviation advances toward FAA Type Certification, with a looming Texas governance vote and a quarterly report t...
Bookings are running below projections as the World Cup 2026 approaches. The shift could force price cuts, staffing c...